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Purpose: We sought to determine the degree to which oxygen extraction fraction 
(OEF) estimated using quantitative susceptibility mapping (QSM) depends on two 
critical acquisition parameters that have a significant impact on acquisition time: 
voxel size and final echo time.
Methods: Four healthy volunteers were imaged using a range of isotropic voxel 
sizes and final echo times. The 0.7 mm data were downsampled at different stages of 
QSM processing by a factor of 2 (to 1.4 mm), 3 (2.1 mm), or 4 (2.8 mm) to determine 
the impact of voxel size on each analysis step. OEF was estimated from 11 veins of 
varying diameter. Inter- and intra- session repeatability were estimated for the opti-
mal protocol by repeat scanning in 10 participants.
Results: Final echo time was found to have no significant effect on OEF. The effect of 
voxel size was significant, with larger voxel sizes underestimating OEF, depending on 
the proximity of the vein to the superficial surface of the brain and on vein diameter. 
The last analysis step of estimating vein OEF values from susceptibility images had 
the largest dependency on voxel size. Inter- session coefficients of variation on OEF 
estimates of between 5.2% and 8.7% are reported, depending on the vein.
Conclusion: QSM acquisition times can be minimized by reducing the final echo 
time but an isotropic voxel size no larger than 1 mm is needed to accurately estimate 
OEF in most medium/large veins in the brain. Such acquisitions can be achieved in 
under 4 min.
K E Y W O R D S
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1 |  INTRODUCTION
Non- invasive imaging measurements of brain oxygenation 
have wide potential scientific and clinical utility, for exam-
ple in Alzheimer disease, stroke, and Parkinson disease.1- 3 
Quantitative susceptibility mapping (QSM) is a promising 
approach to estimate oxygen extraction fraction (OEF) but 
cross- comparisons of studies are undermined by the absence 
of a set of standard, optimized acquisition parameters and 
recommended analysis methods. Establishment of a consis-
tent protocol is also critical for multi- center research stud-
ies. The development of a set of recommendations is likely 
to be a prerequisite to the adoption of these techniques to 
common clinical use. While the endpoint of this process will 
require a consensus opinion as has been achieved for the use 
of arterial spin labeling for the estimation of cerebral blood 
flow (CBF),4 to get to this point the effects of acquisition 
parameters on the accuracy of the OEF estimation needs to 
be determined.
If it is assumed that magnetic susceptibility within veins 
is predominately from deoxygenated hemoglobin, QSM can 
provide an estimate of venous oxygen saturation (SvO2). OEF 
can then be estimated according to5:
where SaO2 is oxygen saturation within arterial blood, typically 
measured using pulse oximetry or assumed to have a value 
of 100%. If CBF (mL blood/min/100 g) to the region is also 
known then the cerebral metabolic rate of oxygen consumption 
(CMRO2 in mmol O2/min/100 g) can be estimated:
where [O2]a is the concentration of oxygen within arterial blood 
(in mmol O2/ mL blood).
Regional OEF measured along with CBF and CMRO2 
using oxygen- 15 positron emission tomography (PET) have 
shown some disease processes are likely to impact oxygen 
extraction on a regional basis.1,3,6- 8 This technique is not 
translatable to wide clinical use due to its high cost and the 
challenging methodology of administering radioactivity 
with a half- life of 2 min. Alternative approaches have been 
developed using MRI such as dual- calibrated fMRI9- 11 and 
quantitative BOLD12 but these in general entail long acqui-
sition times and/or gas challenge and use of physiological 
assumptions in the modelling that may not hold in disease. 
T2- relaxation- under- spin- tagging (TRUST) is the most 
widely used technique which relates the T2 of blood to oxy-
gen saturation,13- 15 with a growing literature investigating its 
sensitivity to disease- related changes.16,17 TRUST requires 
spin labelling of venous blood, generally limited to global 
measurements taken from the superior sagittal sinus (SSS) 
to achieve sufficient signal- to- noise ratio (SNR). A recent at-
tempt to provide regional information applied selective local-
isation of the T2 encoding prior to spin labeling, successfully 
demonstrating hemispherical specificity.18 This would have 
utility for conditions such as stroke but may not be able to 
resolve smaller regions of interest in neurodegenerative dis-
ease. High resolution QSM may provide a better approach to 
estimate regional OEF from SvO2 estimation inside smaller 
veins. OEF can also be estimated using susceptibility- based 
oximetry (SBO)19 but this approach is restricted to straight 
vessels and is sensitive to the angle of the vessel to the exter-
nal field, with measurements, therefore, generally restricted 
to the SSS. QSM is essentially an extension of SBO, allow-
ing quantification of OEF for veins of arbitrary geometry 
and orientation, making it more suitable for regional OEF 
estimation.
QSM reconstructs a voxel- wise map of susceptibility from 
the phase information. Susceptibilities of venous blood- only 
voxels can be used to calculate vessel- specific SvO2 from:
where Δ
vein−CSF is the susceptibility difference between the 




 is the 
susceptibility difference between fully oxygenated red blood 
cells and water (- 0.03 parts per million (ppm) in cgs [centime-
ter/gram/second] units),20 Hct is the hematocrit, and Δ
0
 is the 
susceptibility difference per unit hematocrit between fully ox-
ygenated and fully deoxygenated red blood cells (0.27 ppm in 
cgs units).21 The first term on the right hand side of Equation 
(3) expresses the susceptibility contribution due to the relative 
proportion of deoxygenated to oxygenated red blood cells, and 
the second term a smaller contribution due to the susceptibility 
difference between oxygenated red blood cells and water.
QSM- derived OEF estimates have been compared to those 
from PET in arterial stenosis22 and show expected sensitivity 
to caffeine, hyperoxia, hypercapnia, and acetazolamide.23- 26 
However, the long acquisition times used for high resolution 
regional OEF27 and a lack of consensus on optimal scanning 
parameters hinder translation of QSM to clinical practice and 
undermine comparisons between studies.
Here, we investigate the impact on OEF estimates of min-
imizing acquisition times by increasing voxel size and reduc-
ing the longest or final echo time in a range of vein sizes and 
locations. The increase in acquisition time with voxel size 
follows an inverse power relationship (10 min for 0.7 mm 
isotropic voxel size compared with approximately 4 min for 
a 1 mm voxel size), and a linear relationship with final echo 
time (approximately 4 min for 12 ms and 7 min for 32 ms 
when using 1 mm voxels).
Larger voxel sizes could impact OEF accuracy in a num-
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phase image and the consequential reduction in phase con-
trast, due to the enhanced voxel sensitivity function mixing 
effect28; (2) the degree of discretization of the phase image 
and the impact this has on global processing steps including 
background field estimation, phase unwrapping, and dipole 
inversion; (3) the greater SNR of the phase images; (4) in-
crease in size of the point spread function; (5) worse Gibbs 
ringing; and (6) the greater partial volume of tissue and vein 
within the voxel. We simulated the effects of acquiring at 
different size matrices by performing spatial downsampling 
on the highest resolution data at different stages of process-
ing and compared the resultant OEF estimates to determine 
the relative impact of voxel size at each processing step, and 
whether the impact is different for deep and superficial veins. 
This will only simulate a subset of the potential impacts above 
associated with acquiring at different voxel sizes (namely (1) 
to (3) and (6)) but comparison of OEF estimation between 
simulated and acquired data will determine the relative im-
portance of the other factors.
QSM fits the phase against the echo time on a voxelwise 
basis, enabling the total field to be estimated. The quality of 
the fit can be expected to improve with (1) a larger number 
and (2) a wider range of TEs and so both these factors will 
likely have an impact on both the accuracy and precision of 
the OEF estimate. The OEF- dependent signal within veins 
will decrease relatively quickly with increasing echo time and 
so a shorter final echo time may be sufficient compared to 
what is optimal for tissue susceptibility estimation where T∗
2
 
is longer. Extending the final echo time beyond a certain limit 
may be detrimental if there is no signal left and the data are 
simply adding noise. However additional echoes up to this 
final echo time can only be beneficial, as they will clearly 
add more signal than noise, and with a multi- echo sequence 
these are essentially obtained “for free.” Hence, we decided 
to study the impact of final echo time only and maximise the 
number of echoes up to this point as would always be bene-
ficial in practice.
For our optimized acquisition protocol, we collected test 
re- test data from 10 people in order to determine the inter- 
session repeatability of the OEF estimates in a range of vein 
sizes and locations. Intra- session repeatability was assessed in 
a single participant by seven repeat scans in a single session.
2 |  METHODS
2.1 | Data acquisition
The University of Manchester research ethics committee ap-
proved this study and written informed consent was obtained 
from all participants.
Whole brain images were collected in four healthy vol-
unteers (age range 23- 25, two males) using a sagittal 3D 
multi- echo gradient echo sequence at 3T (Signa PET/MR, 
GE Healthcare, Waukesha, WI) and a 32- channel head coil 
(Nova Medical, Wilmington, MA), with common parameters 
of: field of view (FOV) = 20.8 cm × 20.8 cm × 15.6 cm; 
bandwidth (BW) = ±62.5 kHz; flip angle = 15°; ASSET 
factor = 2 (phase encoding only), with phase encoding in 
the anterior- posterior direction and a bipolar echo collection 
scheme. Bipolar flow compensation gradients are included 
before each echo in the slice encoding direction to null the 
first order gradient moment. In addition, flow compensation 
is achieved in the frequency encoding direction through ap-
plication of a moment nulling gradient before the first echo. 
A Hanning filter was applied but half- Fourier/partial k- space 
was not. The isotropic voxel dimensions used to investigate 
the influence of voxel size are listed in Table 1 alongside 
T A B L E  1  Imaging parameters and acquisition times used to investigate the effects of voxel size and final echo time
Voxel size (mm) #Slices Matrix size #TEs First TE (ms) Final TE (ms) ΔTE (ms) TR (ms)
Acquisition 
time (m:s)
0.7 222 298 × 298 6 3.9 17.2 2.7 25.8 10:07
1 156 208 × 208 8 3.0 16.5 2.0 22.7 04:19
1.5 104 138 × 138 10 2.2 14.5 1.4 19.3 01:40
1.8 86 116 × 116 12 2.0 15.1 1.2 18.9 01:10
2 78 104 × 104 12 1.9 13.9 1.1 17.7 00:54
2.5 62 84 × 84 14 1.7 13.8 0.9 17.3 00:34
3 52 70 × 70 16 1.5 13.9 0.8 17.0 00:25
1 156 208 × 208 6 3.0 12.6 1.9 18.9 03:34
1 156 208 × 208 10 3.0 20.3 1.9 26.4 05:01
1 156 208 × 208 12 3.0 24.2 1.9 30.3 05:44
1 156 208 × 208 14 3.0 28.0 1.9 34.1 06:27
1 156 208 × 208 16 3.0 31.9 1.9 37.9 07:10
Abbreviation: TE, echo time; TR, repetition time.
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their associated echo time parameters and acquisition times. 
As the minimum echo spacing reduces with increasing voxel 
size, the number of echoes was set so that the final echo times 
of each protocol were as similar as possible. This, therefore, 
captures the true gain (in terms of additional echoes) that 
would be made in practice by increasing the voxel size while 
maintaining the final echo time. The 1 mm voxel size acqui-
sition was repeated on each person while varying the number 
of echoes and, therefore, final echo time from 6 to 16 echoes 
in steps of two, as outlined in the bottom half of Table 1. All 
four people were scanned with this complete protocol with 
the individual sequence parameters as shown in the rows in 
Table 1 applied in a randomized order. Intra- session preci-
sion was also estimated in one of the subjects by repeating the 
1- mm six- echo protocol (Table 1, eighth row) seven times in 
a separate session.
Inter- session repeatability was estimated by repeat scan-
ning of 10 people with mild cognitive impairment (MCI) 
(age range 60- 80 y, 5 male) with an interval of 12 ± 12 days 
apart using the 1- mm six- echo protocol (Table 1 eighth row). 
Caffeine intake was controlled by instructing people not to 
consume any caffeinated drinks on the day of the scan. A ve-
nous blood sample was taken approximately 30 min prior to 
the scan from which Hct was measured. SaO2 was measured 
using a pulse oximeter placed on the index finger and values 
were recorded every minute during the QSM scan.
Scanner- reconstructed, post- coil combination magni-
tude, real, and imaginary images were collected in all cases. 
Images were not spatially interpolated during the reconstruc-
tion process.
2.2 | Quantitative susceptibility mapping 
data analysis
All image manipulations were performed in Matlab (v2017a, 
The MathWorks, Inc., Natick, MA). Prior to any image pro-
cessing, each acquired dataset was partitioned by echo po-
larity with odd or even echo datasets analysed separately. 
Susceptibility maps from the collected data were calculated 
F I G U R E  1  Flowchart describing implementation of QSM venography. Susceptibility maps were calculated using the processing steps of field 
estimation (A), phase unwrapping (B), background field removal (C), and dipole inversion (D). E, The resultant susceptibility map was thresholded 
to between 130 and 1000 ppb and a non- oblique cuboid (of variable size depending on the vein anatomy and surroundings) was placed on each of 
11 major veins, example of SS shown here. F, The histogram of the susceptibility values from voxels inside the cuboid and threshold limits was 
analyzed and the 90th percentile, represented by the red line, was used to estimate the susceptibility of the corresponding vein
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from the real and imaginary data as shown in Figure 1 using 
the following QSM pipeline in MEDI+029- 33 (Cornell MRI 
Research Lab) and FSL34 with default parameters unless oth-
erwise stated using the following processing steps:
Step 1: Total field estimation from voxel- wise quadratic 
fitting of signal evolution against TE29,35,36 (Figure 1A) 
and phase unwrapping using region growing37 (Figure 1B) 
producing a total field map.
Step 2: Background field removal using projection-   
onto- dipole- fields30,38 (Figure 1C) after brain masking 
using the brain extraction tool in FSL,39 producing a local 
field map.
Step 3: Dipole inversion using Morphology- Enabled- 
Dipole- Inversion (MEDI) (Figure 1D) incorporating the 
local field map and magnitude image to produce a quanti-
tative susceptibility map. Dipole inversion made use of the 
ventricles as a reference region, delineated automatically 
using a thresholded R∗
2
 map.31 The final susceptibility 
maps from the odd and even echoes were then averaged.
Step 4: A semi- automated method was developed to ex-
tract venous voxels that are predominately blood from 
which OEF values for these vessels were estimated, which 
is detailed in the next section.
2.3 | Semi- automated vein selection
For all calculated maps, a 3D single iteration erosion algorithm 
developed in- house removed the outermost voxels at the edge of 
the brain to minimize tissue- air boundary errors resulting from 
imperfect background field removal. Venous regions of interest 
(ROIs) were then isolated using a lower boundary of 130 ppb 
(parts per billion) and an upper boundary of 1000 ppb to mask 
the image,27 (Figure 1E). For the optimization study, 11 veins 
of varying geometries, locations, and orientations were selected 
from an anatomical textbook40 on the basis of their large size 
and prominence, and are summarized in Table 2. They were 
manually located on the 0.7 mm thresholded map by placing a 
non- oblique cuboid ROI across multiple slices, taking all thres-
holded voxels within the ROI as belonging to the vein follow-
ing visual inspection. Figure 1E shows the ROI corresponding 
to the straight sinus (SS). The vein ROIs determined on the 
0.7 mm map were then resized and applied to the thresholded 
lower resolution maps, rounding the cuboid dimensions to the 
nearest whole number.
2.4 | Vein OEF estimation
The 90th percentile of non- zero voxels within each vein ROI 
was used to estimate the susceptibility in the corresponding 
vein (Figure 1F), a process which was done independently 
for each resolution. If there were fewer than 10 non- zero vox-
els in the ROI, the result was discarded. A subset of six veins 
that could be reliably identified on the 1 mm voxel size image 
was used for the intra- and inter- session repeatability studies: 
SS, vein of Galen (VoG), SSS ||, SSS ⊥, internal cerebral vein 
(ICV), and the largest transverse sinus.
The susceptibility values were then converted to an es-
timate of SvO2 using Equation (3), assuming a Hct of 40% 
and OEF was estimated from Equation (1) assuming SaO2 
of 100% in all participants. In addition, for the inter- session 
repeatability cohort, measured values of Hct from blood sam-
ples were also used to derive SvO2 and SaO2 was estimated 
as the mean of the five measurements taken from the pulse 
oximeter during the scan.
2.4.1 | Voxel size downsampling analysis
The impact of voxel size on different processing steps was 
determined by spatial downsampling of the 0.7 mm data in 
T A B L E  2  Veins included in the analysis
Vein location category Abbreviation Vein
Deep SS Straight Sinus
VoG Vein of Galen
ICVs Internal Cerebral 
Veins
ISS Inferior Sagittal 
Sinus
SCV Small Cerebral 
Vein












LTS Left Transverse 
Sinus





SCV is a perpendicular tributary of the SSS located anterior to the precentral 
gyrus with a similar diameter and orientation across all subjects.
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image space prior to the four different processing steps de-
scribed above: pre step 1 downsampling of the real and im-
aginary images directly output by the scanner, prior to phase 
unwrapping; pre step 2 downsampling of the total field map 
and the magnitude image, prior to background field removal; 
pre step 3 downsampling of the background field removal 
corrected local field map and the magnitude image, prior to 
dipole inversion; and pre step 4 downsampling of the quanti-
tative susceptibility maps prior to the vein identification and 
OEF extraction process outlined above. Downsampling was 
achieved by partitioning the 0.7 mm high resolution image 
into cubic regions of n × n × n adjacent voxels for n = 2, 
3, 4, and creating a lower isotropic resolution image (voxel 
sizes of 1.4 mm, 2.1 mm, and 2.8 mm) of the mean intensity 
within the region.
2.5 | Statistical analysis and data 
comparisons
Statistical analyses were conducted using R 3.6.0 (R Core 
Team, 2019).
2.5.1 | Impact of voxel size and final echo time 
on OEF estimation
The impact of voxel size mediated by vein location on OEF 
was evaluated using a linear mixed model and analysis of 
variance (ANOVA). Voxel size (as a factor), the interaction 
of voxel size and vein location (deep or superficial), and vein 
identity were modelled as fixed effects, while subject was 
set as a random effect. Vein identity is included as a fac-
tor as it is expected that each vein may have different OEF 
due to size and/or region drained, and subject is included 
as there is likely to be a global difference in OEF between 
people. Likewise, the impact of final echo time mediated by 
vein location on OEF was evaluated using a similar model 
but replacing voxel size with final echo time. To evaluate 
further the impact of vein size on OEF estimation we consid-
ered the relationship between cross- sectional area (detailed in 
Supporting Information Text S1, which is available online) 
and OEF at different voxel sizes. Assuming that the estimate 
from the 0.7 mm voxel size data is the most accurate, we 
considered the error in OEF in relation to the 0.7 mm value 
(ΔOEF) as a function of cross- sectional area. We fitted an 
empirical mono- exponential function to this data using the 
fminsearch function in Matlab as a simple visual guide. A 
monoexponential function was chosen in preference to a lin-
ear fit as the line must asymptote to zero for large veins.
OEF estimates from the pre step 1 downsampled images 
(downsampling immediately after acquisition) were com-
pared with OEF estimates from data acquired at different 
resolutions. The final OEF estimates from the acquired data 
were linearly interpolated in order to estimate acquired data 
OEF values for 1.4, 2.1, and 2.8 mm voxels to account for the 
small discrepancies in downsampled and acquired voxel sizes 
(eg, 2 mm acquired vs 2.1 mm downsampled). These data 
were then compared with the pre step 1 downsampled OEF 
values to investigate whether this downsampled data follows 
a similar trend to the acquired data.
2.5.2 | Impact of voxel size within different 
QSM processing stages
To understand the sensitivity of each of the four processing 
steps to voxel size, the input images to each processing step 
were downsampled sequentially and the impact on OEF esti-
mation investigated. The impact of voxel size at each process-
ing stage, mediated by vein location, on OEF was evaluated 
using a linear mixed effect model and ANOVA. The depend-
ent variable was OEF calculated from both data acquired at 
different resolutions and from the highest resolution data 
spatially downsampled at different processing stages. Factors 
were voxel size (0.7, 1.4, 2.1, or 2.8 mm) at acquisition and 
during each of the four processing steps and the interaction of 
each of these with vein location (deep or superficial). As be-
fore, vein identity was modeled as a fixed effect, and subject 
as a random effect. The purpose of this analysis is to deter-
mine during which of the four processing steps the voxel size 
has greatest impact on OEF estimation, specifically to iden-
tify whether the variance of the OEF estimates with voxel 
size for each processing step were significant, regardless of 
voxel size at earlier or subsequent processing steps.
2.5.3 | Intra- and inter- session repeatability
The intra- session repeatability was calculated as coefficient 
of variation (CoVintra) of OEF from the seven repeat meas-





intra and intra are the mean and SD of the OEF estimates 
from the seven repeat measurements, respectively. Veins were 
segmented separately for each repeat measurement.
The inter- session repeatability was estimated for each vein 
following the approach described by Bland and Altman,41 
using:
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where 
inter
 is the within- subject standard deviation, n is the 





 are the OEF estimates for each subject i at the 
first and second scan, respectively. The CoV was calculated as 

inter
 divided by the mean OEF estimate over the 10 participants 
and expressed as a percentage. Inter- session repeatability was 
calculated using fixed SaO2 of 100% and/or fixed Hct of 0.4 
in parallel to use of the individual measurements from pulse 
oximetry and blood samples. To compare precision across the 
four approaches to OEF estimation (fixed SaO2 & fixed Hct, 
measured SaO2 & measured Hct, fixed SaO2 & measured Hct, 
measured SaO2 & fixed Hct), the OEF values calculated were 
compared using ANOVA, with vein identity, subject, and their 
interaction as factors. Residual mean square errors (MSEs) were 
compared as described in Supporting Information Text S2.
3 |  RESULTS
3.1 | Impact of Voxel Size and final echo 
time on OEF estimation
All 11 veins were successfully identified, and their cross- 
sectional areas and diameters were measured in the highest 
resolution QSM maps for the four participants. OEF estimates 
were thus obtained in all veins for all participants at 0.7 mm 
resolution but 15 data points (out of 308 = 11 veins × 4 healthy 
volunteers × 7 voxel sizes, ie, 5%) were discarded at lower res-
olutions due to the presence of fewer than 10 non- zero voxels 
in the ROI (Supporting Information Table S1). The mean ± SE 
OEF measured at 0.7 mm across four participants ranged from 
31.6 ± 3.0% (ISS) to 56.8 ± 0.7% (RTS), depending on the vein. 
Voxel size had a significant effect on OEF (P < .0001, Table 3), 
resulting in underestimation in OEF with increasing voxel size 
(Figure 2A,B). Interaction with vein location category was also 
significant (P < .0001), which can be seen in Figure 2 with (a) 
deep veins showing a greater voxel size dependence than (b) 
superficial veins. Final echo time had no significant effect on 
OEF and no interaction with vein location category (Table 3). 
Vein identity also accounted for significant variance in OEF, 
which may be due to vein size and/or different regional OEF.
To look further at the impact of voxel size on OEF, vein 
cross- sectional area was plotted against ΔOEF for different 
voxel sizes (Figure 3A). For voxel sizes of 1.5 mm or more, 
underestimation was greater in vessels with smaller diame-
ters with larger differences observed from their values ac-
quired at 0.7 mm. For a 1 mm voxel size, little difference 
in OEF estimation compared to 0.7 mm voxel size was ob-
served except for vessels with cross- sectional area below ap-
proximately 20 mm2 (small cerebral vein [SCV] and inferior 
sagittal sinus [ISS]), while for vessels above approximately 
60 mm2 (SSS and right transverse sinus [RTS]) it would ap-
pear that a 2 mm voxel size is sufficient. Figure 3C shows OEF 
values using data downsampled from acquired data at 0.7 mm 
isotropic voxel size pre- processing step 1 with Figure 3B 
showing OEF estimates from acquired data interpolated to 
the same voxel size. It can be seen that the synthetic data do, 
in general, recapitulate the trends seen in the acquired data, 
confirming that further investigation of downsampling at dif-
ferent stages of processing is of potential value to identify the 
impact of voxel size at each processing stage.
3.2 | Impact of voxel size at different QSM 
processing stages
Twenty percent of the data points were discarded due to the 
presence of fewer than 10 voxels in the ROI as outlined in 
Supporting Information Table S2. Results of the ANOVA 
on the remaining data points are shown in Table 4 with plots 
of the significant effects shown in Figure 4. Voxel size has a 
significant impact on processing step 2, suggesting that voxel 
size is critical to accurate background field removal through 
the estimation of the background field map. Furthermore, the 
significance of the interaction between step 2 and vein location 
category confirms that the impact of voxel size on background 
field removal primarily impacts OEF estimation for superficial 
veins as illustrated in Figure 4C. Voxel size also has a signifi-
cant impact on processing step 4 in which vein OEF estimates 
were calculated from the susceptibility map through ROI iden-
tification (Figure 4B). As before, vein identity also accounted 
for significant variance in OEF (Figure 4A). It was noted that 
this appeared to be related to cross- sectional area (shown with 
black crosses on Figure 4A), and a significant correlation was 
found between cross- sectional area and the OEF mean value 
model fits for each vein (r = 0.77, P < .01).
3.3 | Intra- and inter- session repeatability
In the healthy subject, the mean OEF over the seven repeats 
ranged from 27.9% (SCV) to 55.8% (LTS) depending on the 
vein. Intra- session precision of OEF was high (Table 5), with 
the coefficients of variation ranging from 2.1% to 4.8%.
In the participants with MCI, the OEF ranged from 25.5% 
to 51.5% depending on the veins. Bland- Altman analysis 
(Figure 5) yielded inter- session repeatability CoVs (Table 5) 
of 5.2% to 8.7%. No statistically significant differences were 
found between the residual MSEs calculated for any of the 
four options.
4 |  DISCUSSION
In this study, we evaluate the impact of voxel size and final 
echo time on the estimation of regional OEF using QSM in 
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order to minimize acquisition time in four healthy subjects. 
We also assess the inter- session repeatability in 10 partici-
pants with MCI, as well as the intra- session repeatability 
in a single healthy subject. OEF estimates obtained using a 
voxel size of 0.7 mm were in good agreement with results 
reported elsewhere in healthy subjects.42 Eleven veins of 
varying geometries, locations, and orientations were selected 
on the basis of their large size and prominence. Only the six 
largest veins were used in the intra- and inter- repeatability 
study with voxel size 1 mm as other veins could not be reli-
ably identified across all subjects as a consequence of the 
larger voxel sizes, brain masking, background field removal 
errors, or anatomic variation across individuals. Mean OEF 
values in the participants with MCI were in agreement with 
the literature.7,43
The broad range of voxel sizes and final echo times cho-
sen reflected those likely to be used in a clinical environment. 
We observed a significant influence of voxel size on OEF es-
timation (Figure 2A), dependent on vessel size (Figure 3A). 
The decrease in OEF estimates with increasing voxel size 
observed in deep veins, such as the SS, is mostly explained 
by partial volume effects (Table 4 and Figure 4). Voxel sizes 
larger than the vein diameter yield erroneous OEF values 
since they do not contain only blood, as do voxels that are 
smaller than vein diameter located at the vein boundary. The 
ratio between the number of boundary voxels (with lower 
susceptibility) to blood- only voxels (with higher suscepti-
bility) increases with increasing voxel size, causing under-
estimation of OEF (Equation 2). We attempted to reduce this 
effect by considering the 90th percentile of susceptibility val-
ues in the ROI rather than the mean or median. Although the 
voxel within this ROI with the maximum susceptibility is the 
least likely to suffer from partial volume effects, the reliance 
on a single voxel would be vulnerable to noise, therefore, we 
opted to use the 90th percentile instead. This is less effective 
for thinner veins where even the voxel at the 90th percentile 
is likely to suffer from partial volume. The fact that in our 
downsampling simulations voxel size had the biggest and 
most significant impact on OEF estimation at the final pro-
cessing stage of extracting the ROI values from QSM images 
suggests that the impact of voxel size on OEF underestima-
tion can indeed be almost entirely attributed to partial volume 
effects. Note that there is no significant impact of voxel size 
on the acquisition step, suggesting that any residual differ-
ences between the acquired and simulated data, such as Gibbs 
ringing and point spread function, are negligible, supported 
also by the similar trends seen for acquired and downsampled 
data in Figure 3B,C.
The volatile relationship between OEF and voxel size ob-
served for veins located at the brain surface (Figure 2B), such 
as the SSS, may be due to several factors. A key consider-
ation that motivates the classification of veins as deep or su-
perficial is the presence of background field removal errors, 
which occur most prominently at the brain surface. These er-
rors result from the failure of the operating principle of the 
background field removal method, which is used to distin-
guish the background field from the local field, producing an 
erroneous fringe pattern along the brain edge. Although we 
attempted to mitigate this by applying an upper susceptibility 
threshold and surface voxel erosion, this was only effective to 
remove voxels that clearly result in nonsensical susceptibility 
values, leaving other voxels that were more mildly affected 
within the ROI. For superficial vessels, larger voxel sizes 
may, therefore, have introduced erroneously high suscep-
tibility values at the brain edge. The significant interaction 
in our downsampling simulation results between voxel size 
impact on background field removal and vein category (deep 
or superficial) (Table 4 and Figure 4C) supports the notion 
that background field removal errors are most critical at the 
brain surface and lead to erroneously high OEF estimates. 
Superficial veins, therefore, have competing impact of both 
partial volume and background field removal errors as voxel 
size increases, explaining the pattern of first lower and then, 
higher OEF estimates with increasing voxel size (Figure 2B).
We found that a 1 mm voxel size produces little differ-
ence in OEF estimation compared with 0.7 mm voxel size 
Test 1 Df SS MS F value P value
Voxel size 6 7212 1202 21.7 <.0001
Vein identity 10 13135 1314 23.8 <.0001
Voxel size:category 6 3682 614 11.1 <.0001
Residual variance 55.3
Test 2 Df SS MS F value P value
Final echo time 5 72 14 0.4 .87
Vein identity 10 16082 1608 40.8 <.0001
Final echo time:Category 5 83 17 0.4 .83
Residual variance 39.4
Abbreviations: Df (degrees of freedom), SS (Sum of Squares), MS (Mean squares).
T A B L E  3  Analysis of variance for 
the impact of voxel size, or final echo time 
mediated by vein location category (deep or 
superficial) on OEF estimation for all veins
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(Figure 3), except for vessels with cross- sectional area below 
approximately 20 mm2 (diameter of ~5.0 mm), such as the 
SCV and ISS, and has the benefit of reducing acquisition 
time from approximately 10 min to 4 min. Furthermore, for 
vessels above approximately 60 mm2 (diameter of ~8.7 mm), 
such as the SSS and RTS, it would appear that a 2 mm voxel 
size is sufficient, reducing acquisition time further to ap-
proximately 1 min. While it has become common practice to 
shorten acquisition time further using large slice thicknesses, 
this has recently been shown to lead to erroneous suscepti-
bility estimates in tissue.44 Moreover, increasing the voxel 
slice dimensions would be especially problematic when using 
QSM to estimate OEF in the veins, since the narrow profiles 
and often oblique orientations of veins would be difficult 
to image accurately. One limitation of our study is lack of a 
ground truth OEF value with residual partial volume effects 
likely to remain at 0.7 mm, especially in the smallest veins. 
Furthermore, we have not presented any method of correct-
ing for the underestimation of OEF due to partial volume, 
rather presenting methods to avoid it through appropriate 
choice of voxel size for the vein of interest. However, we note 
that other authors have suggested methods to compensate for 
partial volume effects. This can vary from a simple compen-
sation factor included in Equation (3),22,45 to a novel method 
of SBO.46 These may allow accurate estimation of OEF in 
smaller vessels or with larger voxels. However, care would be 
needed where the susceptibility of tissue outside the vessel 
may be altered and in the case of tortuous vessels.
The absence of a significant relationship between final echo 
time and OEF suggests that final echo times and, therefore, 
repetition times can be minimized by collecting as few as six 
bipolar echoes, or three unipolar echoes, down to a final echo 
time of at most 13 ms, which was the minimum we tested. The 
lack of a dependency suggests that 13 ms is sufficient to capture 
the deoxyhemoglobin- related signal decay and that longer final 
echo time is not beneficial in improving the accuracy of the 
phase estimates nor do additional echoes improve the precision. 
Our study was limited by a requirement of the software we used 
to generate our susceptibility maps (MEDI), which has a mini-
mum requirement of three echoes, and as we analyzed odd and 
F I G U R E  2  OEF estimation with increasing isotropic voxel size and final echo time. The top row shows the impact of voxel size on OEF 
estimation for deep veins (A) and superficial veins (B). The bottom row shows the impact of final echo time on OEF estimation for deep veins (C) 
and superficial veins (D). Estimates could not be made in some deep veins for the larger voxel sizes as there were fewer than 10 voxels in the ROI. 
Error bars represent standard error in the mean over the four healthy volunteers. Veins are identified in the key along with their diameters (mean ± 
SD). SAV, superior anastomotic vein; LTS, left transverse sinus; IAVL, inferior anastomotic vein of Labbé
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even echoes separately, we therefore needed at least six bipolar 
echoes. This nonetheless resulted in significant time saving, as 
we were able to halve the acquisition times using a final echo 
time of 12.6 ms rather than 31.9 ms (Table 1).
There are a number of limitations to our study. We neglected 
to include vessel orientation relative to B0 as a factor, as we 
expected the impact to be small.27,47 We note, however, that 
this may have played a role in the heterogeneity of our OEF 
values across vein identity (Figure 4A). Moreover, these dif-
ferences in OEF between veins may have a physiological basis, 
and the indication of reduced OEF in deep veins is supported 
by previous work.48 While flow compensation was included 
in the frequency and slice- encoding directions, it was not in-
corporated in the phase- encoding direction that may have led 
to flow- related artifacts and associated errors in susceptibility 
estimates. However, as phase- encoding gradient amplitudes 
are relatively small, this is less important. Furthermore, such 
artifacts would be expected to get worse with increasing echo 
time.49 We see no obvious change in flow- related displacement 
artifacts with increasing echo time (Supporting Information 
Figure S1), and the lack of association between final echo time 
and susceptibility values (Figure 2) suggests this did not affect 
our susceptibility estimates significantly. Prior to any image 
processing, each acquired dataset was partitioned by echo po-
larity with odd or even echo datasets analyzed separately. This 
was necessary as bipolar readout gradients were used which, 
due principally to differences in eddy currents between the 
gradient directions, manifests as phase discrepancies that led 
to catastrophic artifacts in the susceptibility maps when parti-
tioning was not performed. Previous work has demonstrated ef-
fective correction for the differences in eddy currents enabling 
joint analysis of data with both polarities,50 removing any po-
tential spatial shifts between the odd and even echo polarity 
images. However, we did not observe such spatial shifts in our 
data (Supporting Information Figure S2) and, so, considered 
the averaging process to be adequate.
In this study, we assumed a fixed value of Hct and SaO2 for 
all data processed from the four healthy volunteers. In reality, 
they are likely to vary within and across individuals. We ac-
counted for this when estimating inter- session repeatability by 
measuring these parameters in the MCI cohort. We found that 
using individual measurements does not cause a loss in pre-
cision described by the inter- session CoV and residual MSE 





, which we used to calculate OEF, may 
also vary between individuals introducing additional error 
but this is likely to be very small.20 The fact that intra- session 
CoVs, which were obtained in a younger person using fixed 
SaO2 and Hct, were lower than inter- session CoVs, reflect 
additional sources of inter- session variability, and that could 
include: physiological change in OEF between sessions; dif-
ferences in the acquisition and processing of the data, such 
Test Df SS MS F value P value
Main effects
Acquisition 3 326 109 2.0 .11
Processing step 1: phase 
unwrapping
3 35 12 0.2 .89
Processing step 2: background 
field removal
3 487 162 3.0 .03
Processing step 3: dipole 
inversion
3 124 41 0.8 .52
Processing step 4: ROI 
identification and OEF 
estimation
3 5390 1797 33.0 <.0001
Vein identity 10 8730 873 16.1 <.0001
Interactions
Vein location category by 
acquisition
3 176 59 1.1 .36
Vein location category by 
processing step 1
3 89 30 0.5 .65
Vein location category by 
processing step 2
3 657 219 4.0 .008
Vein location category by 
processing step 3
3 20 7 0.1 .95
Vein location category by 
processing step 4
3 38 13 0.2 .88
Abbreviations: Df, degrees of freedom; SS, sum of squares; MS, mean squares.
T A B L E  4  Analysis of variance for 
the impact of voxel size at each processing 
stage, mediated by vein location categorya a 
Deep or superficial, on OEF estimation for 
all veins.
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F I G U R E  4  Impact of voxel size at different stages of QSM processing. Significant results from Table 4 are depicted regarding ANOVA of 
the impact of voxel size at each processing stage, mediated by vein location category (deep or superficial), with vein identity as a fixed effect. OEF 
mean value model fits are shown for vein identity (A); step 4, impact of voxel size on ROI identification and OEF extraction (B); andstep 2, impact 
of voxel size on background field removal, dependent on vein location category (deep or superficial) (C). OEF varied with vein cross- sectional area 
(A, black x’s, error bars are SDs) and superficial veins (SSS to RTS) have consistently higher OEF values. B, The dependence of OEF on voxel 
size was primarily due to the final step 4 of ROI identification and OEF extraction. C, Voxel size also had a significant impact on background field 
removal, but this was greater for superficial veins than deep veins. SAV, superior anastomotic vein; LTS, left transverse sinus; IAVL, inferior 
anastomotic vein of Labbé
T A B L E  5  Coefficient of variation for OEF estimation
Estimate SS VoG SSS (||) SSS (⊥) ICVs DTS




 &Hct 7.5 8.7 5.2 5.5 8.1 7.3
Measured SaO
2
, Hct = 0.4 7.0 9.1 5.7 6.9 8.3 6.8
SaO
2
 = 100%, Measured Hct 6.5 8.2 4.4 4.6 6.5 6.1
SaO
2
 = 100%, Hct = 0.4 6.2 8.5 5.0 6.1 6.9 5.7
Abbreviation: DTS, dominant transverse sinus.
1326 |   McFADDEN Et Al.
as positioning in the scanner and ROI location. Overall inter- 
session confidence intervals were comparable to those from 
similar studies.15,51 Liu et al15 used TRUST to obtain a co-
efficient of variation of 8.16% for intersession repeatability, 
to which our corresponding estimate (SSS segment parallel 
to B0, measured SaO2, fixed Hct) of 5.8% compares favor-
ably. Moreover, our precision is worse than those obtained in 
a study using SBO of 2.3%.52 The whole brain coefficient of 
variation of 9.3% by Bremmer et al51 using 15- O PET, which 
is considered the gold standard imaging method for OEF, is 
also outside of the higher end of our findings.
5 |  CONCLUSIONS
Regional QSM- OEF can be achieved in under 4 min across a 
wide range of vessels with cross- sectional area greater than 20 
mm2 using a final echo time of 12.6 ms and 1 mm isotropic 
F I G U R E  5  Bland- Altmann plot of inter- session repeatability for OEF. Absolute differences between OEF estimates of both visits for each 
subject are plotted against the average of these estimates by region of interest: SS (A) , VoG (B) , (C) SSS||, SSS (D), ICV (E), and dominant 
transverse sinus (F). The long dotted line represents the mean difference between both visits across 10 participants, while the short dotted lines 
represent the 95% confidence interval. The r and P- values show the results of individual Pearson correlation testing which, after Bonferroni 
correction for multiple comparisons, are not significant
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voxels. The use of larger voxels for major veins such as the SSS 
and RTS may be possible. However, this is complicated by the 
proximity of these vessels to the superficial surface of the brain 
where background field removal errors are more prominent.
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SUPPORTING INFORMATION
Additional Supporting Information may be found online in 
the Supporting Information section.
FIGURE S1 Evidence for lack of flow- related displacement 
artefacts. Top row: magnitude images at two different echo 
times from one of the volunteers scanned with the protocol 
described in the final row of Table 1. There is no obvious spa-
tial displacement of veins at the longer echo time. Bottom row: 
Local field maps calculated from the phase images after phase 
unwrapping and background field removal. Field maps calcu-
lated using phase images up to TE = 16.5 ms (left, correspond-
ing to data from row 2 of Table 1) and 31.9 ms (right, corre-
sponding to data from the final row of Table 1) do not show 
any obvious differences relating to potential flow artefacts that 
might be expected to be worse at the longer echo time
FIGURE S2 QSM images for the even and odd echoes. 
Images are taken from one of the volunteers scanned with 
the protocol described in the final row of Table 1. There is no 
obvious displacement of veins on the QSM maps calculated 
using the even and odd echoes. Cross- hairs which are placed 
at the same voxel location in each image
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TABLE S1 The number of participants (max 4) for whom a 
region was discarded due to an insufficient number of voxels, 
organised by vein and voxel size
TABLE S2 142 data points (out of 704— 11 veins × 4 healthy 
volunteers × 4 resolutions × 4 points of intervention ie, 20%) 
were discarded due to the presence of fewer that 10 voxels in 
the ROI or, in the case of the interpolated data, if either of the 
nearest neighbour acquired data had been excluded
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